InVivo Therapeutics enrolls 7th patient in INSPIRE study: 5 quick points

InVivo Therapeutics enrolled the 7th patient in the INSPIRE study, which is testing the Neuro-Spinal Scaffold implant’s efficacy.

Advertisement

Here are five quick points:

 

1. Charlotte, N.C.-based Carolinas Medical Center enrolled the patient.

 

2. Neurosurgeon Domagoj Coric, MD, implanted the device in the patient about 21 hours post-injury.

 

3. Dr. Coric has implanted the device in three patients.

 

4. The Neuro-Spinal Scaffold is designed to support appositional healing following acute spinal cord injury.

 

5. “This enrollment marks another important step toward completing the INSPIRE study and helping to address this enormous unmet medical need,” said Mark Perrin, CEO and chairman, InVivo.

 

More articles on devices:
DJO Global 2015 net sales hit $308M; Net loss hits $349.9M: 8 things to know
Mesoblast’s Mesenchymal Precursor Cells receives key patent — 5 takeaways
SpineGuard announces full-year 2015 financial results: 9 facts

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.